RBC sales increase
This article was originally published in The Tan Sheet
Executive Summary
First-quarter net sales for RBC Life Sciences increased 18 percent to $6.35 million, the Irving, Texas-based firm announces May 5. Net earnings for the January-March period increased 9 percent to $355,000 compared to $325,000 last year, nutritional supplements manufacturer says. The firm, which specializes in introducing nanotechnology into nutritional and personal care products, says its nutritional segment grew more than 14 percent compared to the year-ago quarter due to an increase in revenues from its international licensees...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.